A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...

BUFFALO-NIAGARA, N.Y., April 17, 2025 /PRNewswire/ - As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off ...

In results published today in Cell Biomaterials, an international team reported that a nanoparticle vaccine displaying two recombinant virus-derived proteins; hemagglutinin (H5) and neuraminidase ...

In results published today in Cell Biomaterials, an international team reported that a nanoparticle vaccine displaying two recombinant virus-derived proteins—hemagglutinin (H5) and neuraminidase ...